ARTICLE | Clinical News
Cerus and Baxter complete Phase III enrollment
March 16, 2000 8:00 AM UTC
CERS and partner BAX completed enrollment of 100 patients in a European Phase III trial of their system to inactivate viruses, bacteria and other pathogens in platelet concentrates intended for transf...